Merck Sharp + Dohme Corp.

David F Cauble, Jr

Timothy J Guzi

M Arshad Siddiqui

Lianyun Zhao

Panduranga Adulla P Reddy

Luis E Torres

Shuyi Tang

Praveen K Tadikonda

Tzu Tshin Wong

The present invention relates to novel heterocyclic amide compounds of Formula I: as disclosed herein or a pharmaceutically acceptable salt, solvate, ester, prodrug or stereoisomer thereof. Also disclosed are compositions comprising said compounds, and methods for using said compounds for treating or preventing a proliferative disease, an anti-proliferative disorder, inflammation, arthritis, a neurological or neurodegenerative disease, a cardiovascular disease, alopecia, a neuronal disease, an ischemic injury, a viral disease or a fungal disease. 

Heterocyclic amide compounds as protein kinase inhibitors

Growing community of inventors

Cambridge, MA, United States of America

David F Cauble, Jr